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“The Impact of Dietary Calcium on Rates of 
Breast Cancer Metastasis to Bone” 
Dr. Urszula Iwaniec and Dr. Russell Turner 
of the OSU Skeletal Biology Laboratory • As a researcher, I want to understand the how and 
why. 
 
• As a pre-medical student, cancer and metastasis is 
a topic I’ll deal with throughout my career. 
 
• As an individual, I’m personally interested in any 
opportunity where science can advance medicine,  
decreasing suffering and increasing quality of life. Cancer: 
 
 2nd highest leading cause of death in US 
 
 Causes 1 in 4 deaths in the US 
 
 Kills 1,600 people in US  every day 
 
 Causes more deaths annually in the US than the next five 
leading causes of death combined 
 Direct Medical Care Costs of Cancer: 
 2007: $103.8 billion 
 2010: $124.6 billion 
 2020: $158 billion (CDC estimated) 
 
http://www.cancer.gov/aboutnci/servingpeople/cancer-statistics/costofcancer 
An additional 125 billion is 
also lost annually due to 
cancer deaths and incapacity. 
 
http://www.hcplive.com/conferences/asco/costs_of_cancer_care/ Breast Cancer (BC)  
 Most common type of cancer affecting women  
 Will affect 1 in 8 US women in their lifetime    
 2nd highest cause of cancer mortality in US women  Late stage breast cancer is highly prone to 
metastasis.  
 
 Prognosis for metastatic BC is poor. 
   
 90% of the deaths attributed to breast cancer are 
from metastases. 
 
 
 
http://www.boneandcancerfoundation.org/pdfs/Breast_Cancer_Q+A.pdf Common metastasis locations: 
 Bone (present in 70% of 
stage IV cancer patients) 
 Lungs 
 Lymph nodes 
 Liver 
 Brain 
 
http://www.boneandcancerfoundation.org/pdfs/Breast_Cancer_Q+A.pdf Resultant symptoms: 
 
 Chronic pain  
 Hypercalcemia (elevated blood Calcium levels)  
 Pathologic fractures (especially of weight bearing 
bones) due to osteolysis or abnormal bone turnover 
 Compression of the spinal cord and nerve roots 
(possibly resulting in paralysis) 
 
One of these occurs on average every 3 to 6 months for a BC 
patient.  Thus, breast cancer metastasis to bone results in a 
severe reduction in the quality and duration of life for 
women with BC.  
  Mechanisms mediating BC metastasis to bone 
are not well understood 
 
 Lack of appropriate animal models 
 
 Lack of non-invasive methods for detecting tumors 
 
 Immune compromised animals and surgical trauma cause 
abnormal bone turnover 
 This study addresses historic problems by: 
 
 Using non-immune compromised mice (“Balb/c” 
strain) to investigate BC pathology in bone using the 
highly malignant “4T1” mouse cancer cell line 
 
 Using a minimally invasive tibial injection approach 
for site-specific metastasis evaluation 
  Administered 4T1 cancer cells 
 
 Monitored cancer progression in living mice with 
non-invasive methods 
 
 Performed necropsy, currently evaluating tumor 
burden, bone turnover and degree of osteolysis 
using assortment of quantitative and qualitative 
techniques. Parathyroid hormone (PTH) is directly involved 
in BC metastasis, as well as the severity of 
metastatic tumors.  Excess PTH, caused by insufficient dietary calcium, 
may be an important and preventable factor affecting 
BC metastasis to bone.  
 
 PTH levels increase with age in most women, largely 
due to insufficient dietary calcium.  
 
 The goal of the research is to test this hypothesis in 
mice that have BC, and are fed diets containing 
adequate or insufficient calcium.  Compared to mice fed adequate calcium, mice fed a 
low calcium diet will experience a higher degree of 
destructive bone pathology. 
 
 Once established in bone, malignant tumors will grow 
more rapidly and be more prone to metastasize again.  
  
Determine the effect of elevated bone 
turnover on BC growth following minimally 
invasive implantation of 4T1 cell in bone.  Bioluminescent Imaging 
 Microscopic computerized tomography 
 Histomorphometry Bioluminescent Imaging, “BLI” 
 4T1 cells tagged with firefly derived Luciferase 
 Following Luciferin injection, location and size of tumors can be 
non-invasively visualized with a sensitive camera 
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Only the 4T1 cancer cells express light Microscopic computerized tomography, “µCT” 
 Allows precise 3D evaluation of bone mass and architecture 
 Measures: 
 
 
 Histomorphometry 
 Provides critical information that cannot be obtained 
by less invasive methods 
 
 Only method for direct analysis of bone cellular 
activity 
 
 Measurement of: 
 Bone quality 
 Bone growth 
 Bone turnover 
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Mice fed low calcium diet experienced greater degree of growth 
and metastasis of 4T1 primary tumors. µCT 3D reconstructions of control and 
treatment groups at same levels in bone 
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Control 1000 4TI Cells If this novel explanation proves accurate, increasing calcium levels 
by eating calcium rich foods or by taking calcium supplements 
may reduce the spread of breast cancer to bone and subsequent 
metastasis to soft tissues in women living with cancer.    
  The results of these studies could quickly alter the way 
the medical community views the spread of BC, and 
these experimental findings could easily be 
implemented in clinical practice. 
http://blog.mysanantonio.com/caregivers-on-demand/2012/01/doctor-and-
patient-communication-how-to-talk-to-your-doctor/ If simple dietary changes – which improve calcium 
homeostasis and consequently reduce PTH levels and 
bone turnover rate – can reduce metastasis of breast 
cancer to bone,  we will have made a major impact on 
one of the most debilitating aspects of the progression of 
BC, one that causes intolerable pain and greatly 
diminishes quality of life for BC patients and survivors.  
Sufficient Dietary 
Calcium 
Decreased serum PTH 
and bone turnover 
Decreased BC to Bone Metastasis 
Decreased malignancy and 
secondary metastasis 
Increased Quality of Life 
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Calcium 
Increased serum PTH 
and bone turnover 
Increased BC to Bone Metastasis 
Increased malignancy and 
secondary metastasis 
Decreased Quality of 
Life 
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